| __timestamp | Pharming Group N.V. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21595165 | 2614539000 |
| Thursday, January 1, 2015 | 6590427 | 3711019000 |
| Friday, January 1, 2016 | 11768542 | 4560733000 |
| Sunday, January 1, 2017 | 92587038 | 5475166000 |
| Monday, January 1, 2018 | 129203843 | 6276700000 |
| Tuesday, January 1, 2019 | 165412447 | 7081200000 |
| Wednesday, January 1, 2020 | 203056430 | 7377200000 |
| Friday, January 1, 2021 | 169670071 | 13634200000 |
| Saturday, January 1, 2022 | 188060000 | 10612500000 |
| Sunday, January 1, 2023 | 220104000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Unlocking the unknown
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Pharming Group N.V. have showcased contrasting trajectories in gross profit. From 2014 to 2023, Regeneron has consistently outperformed Pharming, with its gross profit peaking at approximately $11.3 billion in 2023, a staggering 430% increase from 2014. In contrast, Pharming Group's growth, while positive, is more modest, with a 920% increase over the same period, reaching around $220 million in 2023. This disparity highlights Regeneron's dominant market position and innovative prowess. As the biotech industry continues to evolve, these financial trends offer a glimpse into the strategic maneuvers and market dynamics shaping the future of these two companies.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Regeneron Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Pharming Group N.V.
Gross Profit Trends Compared: AbbVie Inc. vs Pharming Group N.V.
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Pharming Group N.V. Trends
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Viatris Inc. and Pharming Group N.V.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs MorphoSys AG: A Gross Profit Performance Breakdown
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.